- Home
- IMNM vs EIM Comparison
IMNM vs EIM Comparison
Compare IMNM & EIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- EIM
- Stock Information
- Founded
- IMNM 2006
- EIM 2002
- Country
- IMNM United States
- EIM United States
- Employees
- IMNM N/A
- EIM N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- EIM Finance/Investors Services
- Sector
- IMNM Health Care
- EIM Finance
- Exchange
- IMNM Nasdaq
- EIM Nasdaq
- Market Cap
- IMNM 542.6M
- EIM 541.9M
- IPO Year
- IMNM 2020
- EIM N/A
- Fundamental
- Price
- IMNM $7.91
- EIM $9.54
- Analyst Decision
- IMNM Strong Buy
- EIM
- Analyst Count
- IMNM 6
- EIM 0
- Target Price
- IMNM $26.00
- EIM N/A
- AVG Volume (30 Days)
- IMNM 1.7M
- EIM 215.2K
- Earning Date
- IMNM 05-13-2025
- EIM 01-01-0001
- Dividend Yield
- IMNM N/A
- EIM 4.32%
- EPS Growth
- IMNM N/A
- EIM N/A
- EPS
- IMNM N/A
- EIM N/A
- Revenue
- IMNM $9,041,000.00
- EIM N/A
- Revenue This Year
- IMNM N/A
- EIM N/A
- Revenue Next Year
- IMNM $1,259.12
- EIM N/A
- P/E Ratio
- IMNM N/A
- EIM N/A
- Revenue Growth
- IMNM N/A
- EIM N/A
- 52 Week Low
- IMNM $5.15
- EIM $8.61
- 52 Week High
- IMNM $19.07
- EIM $10.51
- Technical
- Relative Strength Index (RSI)
- IMNM 55.28
- EIM 33.52
- Support Level
- IMNM $6.96
- EIM $9.49
- Resistance Level
- IMNM $7.56
- EIM $9.59
- Average True Range (ATR)
- IMNM 0.69
- EIM 0.15
- MACD
- IMNM 0.26
- EIM -0.03
- Stochastic Oscillator
- IMNM 98.22
- EIM 32.93
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About EIM Eaton Vance Municipal Bond
Eaton Vance Municipal Bond Fund is a non-diversified closed-end management investment company. It consists of Municipal bond fund, California municipal bond fund, and New York municipal bond fund. The company's investment objective is to provide current income exempt from regular federal income tax, alternative minimum tax, and taxes in specified states. Its investment plan is to invest in higher quality bonds.